Aligning with these findings, our research discerned that elevated USP19 expression portends a favorable survival outcome in PC, and it is of clinical significance to investigate its specific biological functions and the relevant mechanisms in the progression of PC. The gene discussed is USP19; the disease is pachyonychia congenita.